These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27236079)

  • 21. Stereostructure-activity studies on agonists at the AMPA and kainate subtypes of ionotropic glutamate receptors.
    Johansen TN; Greenwood JR; Frydenvang K; Madsen U; Krogsgaard-Larsen P
    Chirality; 2003 Feb; 15(2):167-79. PubMed ID: 12520509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial agonism and antagonism of the ionotropic glutamate receptor iGLuR5: structures of the ligand-binding core in complex with domoic acid and 2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid.
    Hald H; Naur P; Pickering DS; Sprogøe D; Madsen U; Timmermann DB; Ahring PK; Liljefors T; Schousboe A; Egebjerg J; Gajhede M; Kastrup JS
    J Biol Chem; 2007 Aug; 282(35):25726-36. PubMed ID: 17581823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutamate receptor desensitization is mediated by changes in quaternary structure of the ligand binding domain.
    Schauder DM; Kuybeda O; Zhang J; Klymko K; Bartesaghi A; Borgnia MJ; Mayer ML; Subramaniam S
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):5921-6. PubMed ID: 23530186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoenzymatic synthesis of new 2,4-syn-functionalized (S)-glutamate analogues and structure-activity relationship studies at ionotropic glutamate receptors and excitatory amino acid transporters.
    Assaf Z; Larsen AP; Venskutonytė R; Han L; Abrahamsen B; Nielsen B; Gajhede M; Kastrup JS; Jensen AA; Pickering DS; Frydenvang K; Gefflaut T; Bunch L
    J Med Chem; 2013 Feb; 56(4):1614-28. PubMed ID: 23414088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of the kainate receptor subunit GluR6 agonist-binding domain complexed with domoic acid.
    Nanao MH; Green T; Stern-Bach Y; Heinemann SF; Choe S
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1708-13. PubMed ID: 15677325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding site and ligand flexibility revealed by high resolution crystal structures of GluK1 competitive antagonists.
    Alushin GM; Jane D; Mayer ML
    Neuropharmacology; 2011 Jan; 60(1):126-34. PubMed ID: 20558186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and symmetry inform gating principles of ionotropic glutamate receptors.
    Zhu S; Gouaux E
    Neuropharmacology; 2017 Jan; 112(Pt A):11-15. PubMed ID: 27663701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (2S,4R)-4-methylglutamic acid (SYM 2081): a selective, high-affinity ligand for kainate receptors.
    Zhou LM; Gu ZQ; Costa AM; Yamada KA; Mansson PE; Giordano T; Skolnick P; Jones KA
    J Pharmacol Exp Ther; 1997 Jan; 280(1):422-7. PubMed ID: 8996224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N1-Substituted Quinoxaline-2,3-diones as Kainate Receptor Antagonists: X-ray Crystallography, Structure-Affinity Relationships, and in Vitro Pharmacology.
    Pallesen J; Møllerud S; Frydenvang K; Pickering DS; Bornholdt J; Nielsen B; Pasini D; Han L; Marconi L; Kastrup JS; Johansen TN
    ACS Chem Neurosci; 2019 Mar; 10(3):1841-1853. PubMed ID: 30620174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural basis of kainate subtype glutamate receptor desensitization.
    Meyerson JR; Chittori S; Merk A; Rao P; Han TH; Serpe M; Mayer ML; Subramaniam S
    Nature; 2016 Sep; 537(7621):567-571. PubMed ID: 27580033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tetrameric structure of a glutamate receptor channel.
    Rosenmund C; Stern-Bach Y; Stevens CF
    Science; 1998 Jun; 280(5369):1596-9. PubMed ID: 9616121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ( S)-2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic Acid (AMPA) and Kainate Receptor Ligands: Further Exploration of Bioisosteric Replacements and Structural and Biological Investigation.
    Brogi S; Brindisi M; Butini S; Kshirsagar GU; Maramai S; Chemi G; Gemma S; Campiani G; Novellino E; Fiorenzani P; Pinassi J; Aloisi AM; Gynther M; Venskutonytė R; Han L; Frydenvang K; Kastrup JS; Pickering DS
    J Med Chem; 2018 Mar; 61(5):2124-2130. PubMed ID: 29451794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of the First Highly Selective Antagonist of the GluK3 Kainate Receptor Subtype.
    Chałupnik P; Vialko A; Pickering DS; Hinkkanen M; Donbosco S; Møller TC; Jensen AA; Nielsen B; Bay Y; Kristensen AS; Johansen TN; Łątka K; Bajda M; Szymańska E
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The auxiliary subunits Neto1 and Neto2 have distinct, subunit-dependent effects at recombinant GluK1- and GluK2-containing kainate receptors.
    Fisher JL
    Neuropharmacology; 2015 Dec; 99():471-80. PubMed ID: 26277340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular determinants of kainate receptor trafficking.
    Coussen F
    Neuroscience; 2009 Jan; 158(1):25-35. PubMed ID: 18358623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and structure-activity relationships of novel phenylalanine-based amino acids as kainate receptors ligands.
    Szymańska E; Chałupnik P; Szczepańska K; Cuñado Moral AM; Pickering DS; Nielsen B; Johansen TN; Kieć-Kononowicz K
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5568-5572. PubMed ID: 27765511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small-molecule positive allosteric modulation of homomeric kainate receptors GluK1-3: development of screening assays and insight into GluK3 structure.
    Bay Y; Venskutonytė R; Frantsen SM; Thorsen TS; Musgaard M; Frydenvang K; Francotte P; Pirotte B; Biggin PC; Kristensen AS; Boesen T; Pickering DS; Gajhede M; Kastrup JS
    FEBS J; 2024 Apr; 291(7):1506-1529. PubMed ID: 38145505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural mechanism of glutamate receptor activation and desensitization.
    Meyerson JR; Kumar J; Chittori S; Rao P; Pierson J; Bartesaghi A; Mayer ML; Subramaniam S
    Nature; 2014 Oct; 514(7522):328-34. PubMed ID: 25119039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlating efficacy and desensitization with GluK2 ligand-binding domain movements.
    Nayeem N; Mayans O; Green T
    Open Biol; 2013 May; 3(5):130051. PubMed ID: 23720540
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Møllerud S; Hansen RB; Pallesen J; Temperini P; Pasini D; Bornholt J; Nielsen B; Mamedova E; Chalupnik P; Paternain AV; Lerma J; Diaz-delCastillo M; Andreasen JT; Frydenvang K; Kastrup JS; Johansen TN; Pickering DS
    ACS Chem Neurosci; 2019 Nov; 10(11):4685-4695. PubMed ID: 31622082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.